-
“..The most exciting technology that I have seen in my career come through the laboratory..”. -Mark C Preul-MD, Neurosurgeon, Barrow Neurosurgical Institute.
-
Optiscan’s East China Distributor Biotimes Showcasing Pre-Clinical FIVE2 System at the Annual Meeting of the Chinese Academy of Chinese Scholars.
-
A first look at InVivage®: Optiscan’s new oral cancer imaging device.
-
Optiscan presenter and sponsor at the BioPhotonics career workshop at Swinburne University
-
New 3D tissue culture application collaboration with CSIRO
-
Optiscan Initiates FDA Feedback for Oral Cancer 510(k) Submission
Announcements -
Optiscan Investor presentation presented by Darren Lurie at the AusBiotech Conference Melb 30th Oct – 1st Nov 2019
-
CEO Darren Lurie updates Proactive on the development of its new clinical system for oral cancer screening and surgery, on going clinical trials and new China distributor
-
Optiscan Appoints New China Distributor
Announcements -
World leading hospitals Peter Mac & US Sloan Kettering collaboration to trial Optiscan’s leading Cancer Imaging System
Announcements -
Dr Philip Currie and Lindsay Bussau, PhD presenting on Confocal Endomicroscopy and Breast Cancer at The 17th World Federation for Ultrasound in Medicine and Biology Congress, Melb 6-9th Sept 2019.
-
Optiscan is working with Monash University and University of Michigan investigating alternate explanation of causes of ACL injury